Morimoto and colleagues [1] have found that ALDH1 positive breast cancers are significantly more likely to be ER negative, PR negative, Her2 overexpression, and Ki67 positive, but ALDH1 is not significantly associated with poor clinical outcomes. The gene discussed is ESR1; the disease is breast cancer.